# Fortress Biotech, Inc.: Form 8-K, filed Sep 23, 2024

- Company: [Fortress Biotech, Inc.](/companies/fbio.md) (CIK 1429260)
- Form: 8-K
- Filed: 2024-09-23
- Accepted by EDGAR: Sep 23, 2024, 16:05 ET
- Period: 2024-09-19
- Accession: 0001104659-24-102033
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1429260/000110465924102033/tm2424497d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1429260/000110465924102033/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1429260/000110465924102033/tm2424497d1_8k.htm

Filed Sep 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-102033. Last ingested by Listed: Nov 14, 2026, 11:27 ET. No prices; not investment advice.
